Story perspectives
Trump's Tylenol Claims Spark Autism Medication Controversy
3/6/2026
1 of 1
Story summary
- The Lancet study links U.S. President Donald J. Trump’s statements about Tylenol and autism to a 10% drop in Tylenol orders for pregnant women and a 71% rise in leucovorin prescriptions for children.
- Medical groups warned against using leucovorin for autism, but some families pursued it after the remarks.
- Dr. Susan Sirota criticized the politicization of healthcare, saying it harms patient care.
